Skip to content

Treatment with HAART reduces liver-related mortality in HIV/HCV coinfected patients

Tipranavir now available for emergency use in UK

Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

African-Americans, Latinos and gay men bear the brunt of new US HIV infections

HAART can be safely delayed until CD4 cell count falls to 200, provided individuals are adherent

UNAIDS: Injecting drug use fuelling exploding HIV epidemics

UNAIDS: Gay men still the group most affected by HIV in many rich countries

UNAIDS: HIV prevalence increases 10% in South America and Caribbean

UNAIDS says one in five adults now HIV-positive in southern Africa